Over 1150 Total Lots Up For Auction at Five Locations - MN 08/24, TX 08/25, CA 08/26, NY 08/30, TX 09/01

Philips introduces next-generation Digital Pathology Suite, IntelliSite

Press releases may be edited for formatting or style | October 19, 2021 Health IT

"MEDIPATH is focused on accelerating the path of augmented pathology by slide digitalization on all our technical platforms. We are very excited to leverage the new Philips Digital Pathology Suite, including the Pathology Scanner SG300 and Pathology Workspace with de-identification tools, for each of our sites," said Stephane Rossat, Director for innovation, science and project management at MEDIPATH, a French Pathology group with a network of 11 technical labs. "Following the first days of installation, the solution is already proving easy to use, with images generated more quickly, while the quality and sharpness of the images produced is experienced to be superior. The Philips Digital Pathology Suite is the solution that our organization needs to expand our digital pathology capabilities and activate our transformation [1]."

Integrated intelligence and automation across smart diagnostic systems

Precision medicine has increased the volume and complexity of workloads, with pathology labs worldwide facing a shortage of skilled staff. Within the diagnosis and staging of cancer, pathology information is combined with data from multiple disciplines, including radiology, pathology and genomics, to deliver the diagnostic precision required for highly personalized care. There is an urgent need for solutions that combine operational efficiency, team-working, expertise sharing, and enterprise-wide informatics to make the most of a pathology lab's human resources.

Through breakthrough innovations and partnerships, Philips integrates intelligence and automation into its Precision Diagnosis portfolio, including smart diagnostic systems, integrated workflow solutions with the aim to transform departmental operations, advanced informatics that enhance diagnostic confidence, and care pathway solutions that allow medical professionals to tailor treatment to individual patients. By developing and integrating AI-enabled applications, the company aims to enhance the ability to turn data into actionable insights and drive the right care in the right sequence at the right time.

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being, and enabling better outcomes across the health continuum – from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2020 sales of EUR 17.3 billion and employs approximately 77,000 employees with sales and services in more than 100 countries.

Back to HCB News

You Must Be Logged In To Post A Comment